El-Nile Co. for Pharmaceuticals & Chemical Industries (NIPH) Financial Statements
Annual financial statement highlights for El-Nile Co. for Pharmaceuticals & Chemical Industries, in Egyptian pounds (EGP) covering fiscal years 2006–2025. Figures are updated weekly from EGX filings via TradingView.
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Total assets | Total debt | DPS |
|---|---|---|---|---|---|---|---|
| 2025 | 1.29B | 125.73M | 2.7896 | -472.82M | 2.32B | 988.73M | 2.00 |
| 2024 | 1.14B | 90.23M | 2.3599 | -155.47M | 1.47B | 575.28M | 2.4695 |
| 2023 | 1.01B | 119.21M | 3.118 | -283.95M | 1.04B | 212.49M | 1.3241 |
| 2022 | 876.78M | 89.67M | 2.3454 | -43.09M | 769.38M | 79.78M | 0.7865 |
| 2021 | 755.51M | 64.42M | 1.6849 | 75.18M | 720.14M | 43.39M | 0.5296 |
| 2020 | 812.54M | 93.38M | 2.4425 | 44.53M | 679.96M | 43.87M | 0.2648 |
| 2019 | 638.27M | 6.7M | 0.1751 | 70.51M | 574.73M | 74.63M | 0.00 |
| 2018 | 459.93M | -17.59M | -0.4601 | -38.04M | 618.27M | 86.11M | 0.00 |
| 2017 | 417.74M | 23.19M | 0.6064 | -5.28M | 568.87M | 46.09M | 0.2701 |
| 2016 | 330.46M | 8.66M | 0.2264 | -4.27M | 421.49M | 0 | 0.1192 |
| 2015 | 287.46M | 17.92M | 0.4687 | -5.09M | 414.69M | 0 | 0.1933 |
| 2014 | 330.08M | 17.13M | 0.4481 | 31.96M | 427.29M | 0 | 0.1933 |
| 2013 | 351.69M | 22.28M | 0.5828 | 4.38M | 449.31M | 0 | 0.2857 |
| 2012 | 342.79M | 25.31M | 0.662 | 30.69M | 456.29M | 0 | 0.3416 |
| 2011 | 337.81M | 48.09M | — | 22.52M | 453.77M | 0 | 0.6515 |
| 2010 | 341.46M | 61.31M | — | 48.8M | 430.44M | 0 | 0.00 |
| 2009 | 331.61M | 55.04M | — | -3.31M | 402.29M | 0 | 0.7803 |
| 2008 | 316.77M | 54.26M | — | 41.43M | 372.97M | 0 | 0.2354 |
| 2007 | 333.74M | 50.78M | — | 22.61M | 344.32M | 89,796.42 | 0.7215 |
| 2006 | 304.16M | 45.96M | — | 57.51M | 321.39M | 1.5M | 0.255 |
All figures in EGP. Source: company disclosures to the Egyptian Exchange via TradingView; updated weekly.